Search hospitals

>

Arizona

>

Tucson

University of Arizona Cancer Center-North Campus

Claim this profile

Tucson, Arizona 85719

Global Leader in Cancer

Global Leader in Breast Cancer

Conducts research for Lung Cancer

Conducts research for Pancreatic Cancer

Conducts research for Melanoma

491 reported clinical trials

53 medical researchers

Photo of University of Arizona Cancer Center-North Campus in TucsonPhoto of University of Arizona Cancer Center-North Campus in TucsonPhoto of University of Arizona Cancer Center-North Campus in Tucson

Summary

University of Arizona Cancer Center-North Campus is a medical facility located in Tucson, Arizona. This center is recognized for care of Cancer, Breast Cancer, Lung Cancer, Pancreatic Cancer, Melanoma and other specialties. University of Arizona Cancer Center-North Campus is involved with conducting 491 clinical trials across 509 conditions. There are 53 research doctors associated with this hospital, such as Holly E. Pariury, Pavani Chalasani, Rachna Shroff, M.D., and Aaron Scott, MD.

Area of expertise

1

Cancer

Global Leader

University of Arizona Cancer Center-North Campus has run 78 trials for Cancer. Some of their research focus areas include:

Stage IV
Stage III
Stage I
2

Breast Cancer

Global Leader

University of Arizona Cancer Center-North Campus has run 77 trials for Breast Cancer. Some of their research focus areas include:

Stage IV
HER2 negative
ER positive

Top PIs

Clinical Trials running at University of Arizona Cancer Center-North Campus

Breast Cancer

Bladder Cancer

Lung Cancer

Kidney Cancer

Cancer

Prostate Cancer

Bladder Carcinoma

Lymphoma

Ovarian Cancer

Testicular cancer

Image of trial facility.

Radiation and HER2-Targeted Therapy

for Breast Cancer

This Phase III trial compares the recurrence-free interval (RFI) among patients with early-stage, low risk HER2+ breast cancer who undergo breast conserving surgery and receive HER2-directed therapy, and are randomized to not receive adjuvant breast radiotherapy versus those who are randomized to receive adjuvant radiotherapy per the standard of care.

Recruiting

2 awards

Phase 3

15 criteria

Image of trial facility.

Durvalumab + Chemotherapy

for Breast Cancer

This phase III trial compares the addition of an immunotherapy drug (durvalumab) to usual chemotherapy versus usual chemotherapy alone in treating patients with MammaPrint High 2 Risk (MP2) stage II-III hormone receptor positive, HER2 negative breast cancer. Immunotherapy with monoclonal antibodies, such as durvalumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Chemotherapy drugs, such as paclitaxel, doxorubicin, and cyclophosphamide work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. There is some evidence from previous clinical trials that people who have a MammaPrint High 2 Risk result may be more likely to respond to chemotherapy and immunotherapy. Adding durvalumab to usual chemotherapy may be able to prevent the cancer from returning for patients with MP2 stage II-III hormone receptor positive, HER2 negative breast cancer.

Recruiting

2 awards

Phase 3

40 criteria

Image of trial facility.

Omitting Radiation Therapy

for Breast Cancer

The purpose of this study is to compare the effects on low risk breast cancer receiving usual care that includes regional radiation therapy, with receiving no regional radiation therapy. Researchers want to see if not giving this type of radiation treatment works as well at preventing breast cancer from coming back.

Recruiting

2 awards

Phase 3

19 criteria

Similar Hospitals nearby

Frequently asked questions

What kind of research happens at University of Arizona Cancer Center-North Campus?

Where is University of Arizona Cancer Center-North Campus located?

Who should I call to ask about financial aid or insurance network?

What insurance does University of Arizona Cancer Center-North Campus accept?

What awards or recognition has University of Arizona Cancer Center-North Campus received?